para -Sulfonatocalix[4]arene and polyamidoamine dendrimer nanocomplexes as delivery vehicles for a novel platinum anticancer agent
- 1 November 2017
- journal article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 176, 1-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activityJournal of Inorganic Biochemistry, 2017
- Investigating the cytotoxicity of platinum(II) complexes incorporating bidentate pyridyl-1,2,3-triazole “click” ligandsJournal of Inorganic Biochemistry, 2016
- Biodegradable polymer–platinum drug conjugates to overcome platinum drug resistanceRSC Advances, 2015
- The state-of-play and future of platinum drugsEndocrine-Related Cancer, 2015
- Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell linesBritish Journal of Cancer, 2014
- Synthetic Methods for the Preparation of Platinum Anticancer ComplexesChemical Reviews, 2013
- Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalatorInvestigational New Drugs, 2010
- Substituted β-Cyclodextrin and Calix[4]arene As Encapsulatory Vehicles for Platinum(II)-Based DNA IntercalatorsInorganic Chemistry, 2008
- Novel platinum(ii)-based anticancer complexes and molecular hosts as their drug delivery vehiclesDalton Transactions, 2007
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007